Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Bronchogenic × camrelizumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 9 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Uterine Cervical Neoplasms 2 Nasopharyngeal Carcinoma 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Cervical Cancer Metastatic 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma 2 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Non-squamous Non-small-cell Lung Cancer 1 Mouth Neoplasms 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Leukemia, Myeloid, Acute 1 Laryngeal Neoplasms 1 Gestational Trophoblastic Disease 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Squamour Cell Cancer 1 Endometrioid Endometrial Cancer 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Carboplatin 7 pembrolizumab 4 Pemetrexed 4 Paclitaxel 4 Cisplatin 3 selpercatinib 2 pralsetinib 2 durvalumab 2 atezolizumab 2 Radiosurgery 2 Gemcitabine 2 taletrectinib 1 repotrectinib 1 ceralasertib 1 cemiplimab 1 Platinum Compounds 1 Nivolumab 1 Interleukin-15 1 Docetaxel 1 Blood Specimen Collection 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡